Sysmex Corporation
Research Sysmex Corporation (6869.T) on Bullrun: market cap JPY 1.12T, P/E 29.1, dividend yield 2.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6869.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyJPY
- Market capJPY 1.12T
- P/E29.1
- Dividend yield2.1%
- Financial periodFY2026
- RevenueJPY 500.01B
- Revenue growth-1.7%
- Net incomeJPY 35.46B
- Free cash flowJPY 22.88B
- Gross margin51.1%
Valuation Snapshot
latest market cap is JPY 1.12T; P/E is 29.1; dividend yield is 2.1%.
Peer valuation comparison
Latest P/E is 29.06x versus a Healthcare sector median of 21.69x (34.0% above).
Latest dividend yield is 2.09% versus a Healthcare sector median of 2.41% (13.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 500.01B | JPY 35.46B | JPY 22.88B | 51.1% | 56.89 | JPY 84.12B | JPY 70.48B | JPY 505.00B |
| FY2025 | JPY 508.64B | JPY 53.67B | JPY 38.29B | 53.5% | 86.05 | JPY 89.57B | JPY 64.74B | JPY 463.78B |
| FY2024 | JPY 461.51B | JPY 49.64B | JPY 13.71B | 52.5% | 79.24 | JPY 75.51B | JPY 55.34B | JPY 432.05B |
| FY2023 | JPY 410.50B | JPY 45.78B | JPY 26.33B | 52.6% | 72.91 | JPY 69.46B | JPY 22.59B | JPY 387.67B |
| FY2022 | n/a | n/a | n/a | n/a | 70.16 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 1.12T | 29.1 | 2.2% | 40 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 40 JPY, yield 2.1%.
| Year | Dividends/share |
|---|---|
| FY2026 | 39 JPY |
| FY2025 | 35 JPY |
| FY2024 | 29 JPY |
| FY2023 | 28 JPY |
| FY2022 | 26.33 JPY |
About Sysmex Corporation
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers hematology, a major test routinely included in blood tests; Flow Cytometry (FCM) analyzes cell properties by irradiating individual cells with a laser and measuring the intensity of light scattering and fluorescence; urinalysis test checks for the presence of glucose, proteins, and blood in urine; clinical chemistry; hemostasis; immunochemistry; cancer gene testing;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sysmex Corporation's market cap?
Sysmex Corporation's market capitalization is JPY 1.12T.
What is Sysmex Corporation's P/E ratio?
Sysmex Corporation's price-to-earnings (P/E) ratio is 29.1.
Does Sysmex Corporation pay a dividend?
Sysmex Corporation has a dividend yield of 2.1%.
What does Sysmex Corporation do?
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers hematology, a major test routinely included in blood tests; Flow Cytometry (FCM) analyzes cell properties by irradiating individual cells with a laser and measuring the intensity of light scattering and fluorescence; urinalysis test checks for the presence of glucose, proteins, and blood in urine; clinical chemistry; hemostasis; immunochemistry; cancer gene testing; and antimicrobial susceptibility testing.